Table of Content

1. Service Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations

2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Global Biotechnology Contract Manufacturing Market Outlook
4.1. Market Size & Forecast
4.1.1. By Value
4.2. Market Share & Forecast
4.2.1. By Service (Manufacturing, Formulation and Fill-Finish, Packaging and Labeling, Other services)
4.2.2. By Type (Biologic Drug Substance Manufacturing, Biologic Drug Product, Manufacturing)
4.2.3. By Scale of Operation (Commercial Operations, Clinical Operations)
4.2.4. By Therapeutic Area (Autoimmune Diseases, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Neurology, Other Therapeutic Areas)
4.2.5. By Region
4.2.6. By Company (2023)
4.3. Market Map
4.3.1. By Service
4.3.2. By Type
4.3.3. By Scale of Operation
4.3.4. By Therapeutic Area
4.3.5. By Region

5. Asia Pacific Biotechnology Contract Manufacturing Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Service
5.2.2. By Type
5.2.3. By Scale of Operation
5.2.4. By Therapeutic Area
5.2.5. By Country
5.3. Asia Pacific: Country Analysis
5.3.1. China Biotechnology Contract Manufacturing Market Outlook
5.3.1.1. Market Size & Forecast
5.3.1.1.1. By Value
5.3.1.2. Market Share & Forecast
5.3.1.2.1. By Service
5.3.1.2.2. By Type
5.3.1.2.3. By Scale of Operation
5.3.1.2.4. By Therapeutic Area
5.3.2. India Biotechnology Contract Manufacturing Market Outlook
5.3.2.1. Market Size & Forecast
5.3.2.1.1. By Value
5.3.2.2. Market Share & Forecast
5.3.2.2.1. By Service
5.3.2.2.2. By Type
5.3.2.2.3. By Scale of Operation
5.3.2.2.4. By Therapeutic Area
5.3.3. Australia Biotechnology Contract Manufacturing Market Outlook
5.3.3.1. Market Size & Forecast
5.3.3.1.1. By Value
5.3.3.2. Market Share & Forecast
5.3.3.2.1. By Service
5.3.3.2.2. By Type
5.3.3.2.3. By Scale of Operation
5.3.3.2.4. By Therapeutic Area
5.3.4. Japan Biotechnology Contract Manufacturing Market Outlook
5.3.4.1. Market Size & Forecast
5.3.4.1.1. By Value
5.3.4.2. Market Share & Forecast
5.3.4.2.1. By Service
5.3.4.2.2. By Type
5.3.4.2.3. By Scale of Operation
5.3.4.2.4. By Therapeutic Area
5.3.5. South Korea Biotechnology Contract Manufacturing Market Outlook
5.3.5.1. Market Size & Forecast
5.3.5.1.1. By Value
5.3.5.2. Market Share & Forecast
5.3.5.2.1. By Service
5.3.5.2.2. By Type
5.3.5.2.3. By Scale of Operation
5.3.5.2.4. By Therapeutic Area

6. Europe Biotechnology Contract Manufacturing Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Service
6.2.2. By Type
6.2.3. By Scale of Operation
6.2.4. By Therapeutic Area
6.2.5. By Country
6.3. Europe: Country Analysis
6.3.1. France Biotechnology Contract Manufacturing Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Service
6.3.1.2.2. By Type
6.3.1.2.3. By Scale of Operation
6.3.1.2.4. By Therapeutic Area
6.3.2. Germany Biotechnology Contract Manufacturing Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Service
6.3.2.2.2. By Type
6.3.2.2.3. By Scale of Operation
6.3.2.2.4. By Therapeutic Area
6.3.3. Spain Biotechnology Contract Manufacturing Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Service
6.3.3.2.2. By Type
6.3.3.2.3. By Scale of Operation
6.3.3.2.4. By Therapeutic Area
6.3.4. Italy Biotechnology Contract Manufacturing Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Service
6.3.4.2.2. By Type
6.3.4.2.3. By Scale of Operation
6.3.4.2.4. By Therapeutic Area
6.3.5. United Kingdom Biotechnology Contract Manufacturing Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Service
6.3.5.2.2. By Type
6.3.5.2.3. By Scale of Operation
6.3.5.2.4. By Therapeutic Area

7. North America Biotechnology Contract Manufacturing Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Service
7.2.2. By Type
7.2.3. By Scale of Operation
7.2.4. By Therapeutic Area
7.2.5. By Country
7.3. North America: Country Analysis
7.3.1. United States Biotechnology Contract Manufacturing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Service
7.3.1.2.2. By Type
7.3.1.2.3. By Scale of Operation
7.3.1.2.4. By Therapeutic Area
7.3.2. Mexico Biotechnology Contract Manufacturing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Service
7.3.2.2.2. By Type
7.3.2.2.3. By Scale of Operation
7.3.2.2.4. By Therapeutic Area
7.3.3. Canada Biotechnology Contract Manufacturing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Service
7.3.3.2.2. By Type
7.3.3.2.3. By Scale of Operation
7.3.3.2.4. By Therapeutic Area
8. South America Biotechnology Contract Manufacturing Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Service
8.2.2. By Type
8.2.3. By Scale of Operation
8.2.4. By Therapeutic Area
8.2.5. By Country
8.3. South America: Country Analysis
8.3.1. Brazil Biotechnology Contract Manufacturing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Service
8.3.1.2.2. By Type
8.3.1.2.3. By Scale of Operation
8.3.1.2.4. By Therapeutic Area
8.3.2. Argentina Biotechnology Contract Manufacturing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Service
8.3.2.2.2. By Type
8.3.2.2.3. By Scale of Operation
8.3.2.2.4. By Therapeutic Area
8.3.3. Colombia Biotechnology Contract Manufacturing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Service
8.3.3.2.2. By Type
8.3.3.2.3. By Scale of Operation
8.3.3.2.4. By Therapeutic Area
9. Middle East and Africa Biotechnology Contract Manufacturing Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Service
9.2.2. By Type
9.2.3. By Scale of Operation
9.2.4. By Therapeutic Area
9.2.5. By Country
9.3. MEA: Country Analysis
9.3.1. South Africa Biotechnology Contract Manufacturing Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Service
9.3.1.2.2. By Type
9.3.1.2.3. By Scale of Operation
9.3.1.2.4. By Therapeutic Area
9.3.2. Saudi Arabia Biotechnology Contract Manufacturing Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Service
9.3.2.2.2. By Type
9.3.2.2.3. By Scale of Operation
9.3.2.2.4. By Therapeutic Area
9.3.3. UAE Biotechnology Contract Manufacturing Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Service
9.3.3.2.2. By Type
9.3.3.2.3. By Scale of Operation
9.3.3.2.4. By Therapeutic Area

10. Market Dynamics
10.1. Drivers
10.2. Challenges

11. Market Trends & Developments
11.1. Recent Developments
11.2. Product Launches
11.3. Mergers & Acquisitions

12. Global Biotechnology Contract Manufacturing Market: SWOT Analysis

13. Porter’s Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Product

14. Competitive Landscape
14.1. Lonza Group
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Products & Services
14.1.4. Current Capacity Analysis
14.1.5. Financials (In case of listed)
14.1.6. Recent Developments
14.1.7. SWOT Analysis
14.2. Thermo Fisher Scientific Inc
14.3. Wuxi Biologics
14.4. Catalent, Inc.
14.5. Samsung Biologics
14.6. Boehringer Ingelheim International Gmbh
14.7. Fujifilm Holdings Corporation
14.8. Abbvie Inc
14.9. Eurofins Scientific
14.10. Genscript Biotech Corporation

15. Strategic Recommendations

16. About Us & Disclaimer